TypeDrawer/FileDate ModifiedSize

pdf
(DOM) Coronavirus Contingency Safe Administration of Medicines from Original Packs (2) 11:38 04/07/2020891.5k

pdf
1 Feedback Form 12:18 12/06/201878.5k

pdf
1 Non Formulary Rationale Form 2018 12:18 12/06/201812.7k

pdf
1 Inhixa Patient Instruction Compliance (002) 16:44 01/10/2019393.3k

pdf
1st Line Emollients Reviewed 2021 13:02 08/24/2021218.1k

pdf
1st Line Emollients 09:21 07/19/2018532.8k

pdf
1st Line Emollients Sept17 09:11 07/10/2018524k

pdf
2 Feedback Form 12:29 12/06/201879k

pdf
2 Non Formulary Rationale Form 2018 12:29 12/06/201813.1k

pdf
3 Feedback Form 12:33 12/06/201879k

pdf
3 Non Formulary Rationale Form 2018 12:33 12/06/201813.1k

pdf
3 versus 6 Years of Zoledronate Black 2010 09:11 07/10/2018339.8k

pdf
05 19 Urinary Incontinence Product Booklet (002) 10:56 05/29/20191.3M

pdf
22 CS Upadacitinib for AS 15:30 12/21/2022150.5k

docx
124 Uk Form Annex4 Letter MHRA Revised 12:15 10/19/201892.9k

pdf
124 Uk Form Annex4 Letter MHRA Revised 10:40 11/13/2018341.1k

docx
1103 MASTER Re Formatted Formulary Proposal Form Feb 2019 TL 10:34 03/29/201968.3k

pdf
2016 17 Safety Bulletin Dosulepin 11:48 09/20/2018705.9k

docx
2018 04 11 Management of Chlamydia 09:11 07/10/201860.4k

pdf
2018 10 24 FINAL DHPC Epilim Chrono Shortage (002) 11:44 11/13/2018679.9k

pdf
2018 Updated Guideline for Eflornithine 09:36 10/19/2018377.1k

pdf
2018 19 Dipipanone Cyclizine Safety Bulletin 16:10 04/02/2019469.9k

pdf
2018 19 Meprobamate Safety Bulletin 16:04 04/02/2019452.6k

pdf
2018 Wessex IF Guidelines Final 11:49 10/04/20181.3M

pdf
2018 Wessex IF Guidelinesv2 09:11 07/10/20181.6M

pdf
2022 CS (NICE TA274) Ranibizumab Diabetic Macular Oedema 12:30 12/23/2022139.9k

pdf
2022 CS Ciclosporin in Dry Eye 15:21 12/22/202294.7k

pdf
2023 Oct Bulletin METHYLPHENIDATE & Other ADHD Meds Shortage V3 11:54 11/01/2023268.9k

pdf
07648 Vaccine Ordering for 2018-19 Influenza Season GPpharm 05022018 Doc 09:11 07/10/2018333.8k

pdf
171018 Dorset Moisture Pathway 10:55 10/17/2018221k

pdf
241018 Moisture Pathway for Pan Dorset Trust V7 13:41 10/24/2018221k

pdf
22102018 Dilantin 30 (phenytoin) PIL (Canada) 11:26 11/13/2018164.6k

pdf
22102018 Dilantin 30 (phenytoin) Product Monograph (Canada) 11:26 11/13/2018224k

pdf
22102018 Epanutin (phenytoin) 30mg5ml Oral Suspension– Supply Disruption 11:27 11/13/2018125.3k

pdf
28092018 EpiPen and EpiPen Junior (adrenaline Auto Injector Devices) – Supply Disruption 11:32 11/13/2018156.4k

pdf
AAI QAs for Pharmacies and Dispensing Practices 5112018 09:35 11/13/2018515k

pdf
ACBS Product Formulary Paed Products Apr 17 09:11 07/10/2018393k

pdf
ACCESSING OSELTAMIVIR CHRISTMAS 2022 13:03 12/23/2022166k

pdf
ATRIAL FIBRILLATION TREATMENT PATHWAY GUIDELINE 09:10 07/10/2018327.2k

pdf
Abstral Comissioning Statement Final May 2014 09:11 07/10/2018216.9k

pdf
Acamprosate SCG V2 1 Final Version 15:05 08/21/2023381.4k

pdf
Accessing Medicines for Adults at End of Life in the Community July 2023 12:25 08/01/2023192.1k

pdf
Acne Vulgaris Pathway 2017 09:11 07/10/2018413.7k

pdf
Acne Vulgaris Pathway 2018 09:53 02/27/2019658.8k

pdf
Actinic Keratosis Pathway Primary Care Aug 20 15:04 08/21/2020425.6k

pdf
Actinic Keratosis Pway Pcare V4 March 2015 09:11 07/10/2018481.7k

pdf
Actinic Keratosis Pathway September 17 09:11 07/10/2018698.1k

pdf
Actinic Keratosis Pathway Primary Care Nov 2022 15:52 12/21/2022435.8k

pdf
Adult Asthma Guideline 2022 Dorset Version 10 15:55 12/21/2022388.6k

pdf
Adult Asthma Guideline 2022 Dorset Version 12 May 23 13:41 08/23/2023354.6k

pdf
Adult ONS Formulary Sept 17 09:10 07/10/2018262.8k

pdf
Anal Irrigation Pathway Updated 2019 11:25 05/24/2019157.3k

pdf
Anti Microbial Product Information for the Treatment of Infected Critically Colonised Wounds Updated 2021 14:14 12/07/2021132.9k

pdf
Anticipatory Prescribing at the End of Life in the Community July 23 12:26 08/01/2023229.7k

jpg
Antimicrobial SB Sticker 10:31 11/16/201882.3k

docx
Antimicrobial Management of Chlamydia BASHH Update 15:27 12/28/2018371.6k

pdf
Antimicrobial Product Info 2018 FINAL 09:10 07/10/2018144.7k

pdf
Antipsychotic Monitoring and Reviews MOG 22 10:01 08/18/2022277.3k

pdf
Appendix 1 C Pharm Pall Care Drugs & Pharmacies 2017 11:54 08/10/2018384.1k

pdf
Apremilast Commissioning Statement for Psoriasis Feb 17 09:10 07/10/2018366.9k

pdf
Apremilast Commissioning Statement 2019 13:10 02/27/2020568.4k

pdf
Apremilast Commissioning Statement for Psoriatic Arthritis May 17 09:10 07/10/2018341k

pdf
April 2019 KTTT 15:49 05/02/2019448.1k

pdf
Aripiprazole for Bipolar I in Adolescents 09:10 07/10/2018267.1k

pdf
Asthma Steroid Inhalers Guidance May19 12:28 08/02/2019564.4k

pdf
Asthma Inhalers Diagram June 17 09:10 07/10/2018452.2k

pdf
Avatrombopag Commissioning Statement NICE TA 626 V1 15:36 07/30/2020121.6k

pdf
BAD Specials List 2014 09:10 07/10/2018717.3k

pdf
BASH Patient Information Sheet Verapamil for Cluster Headache 15:47 05/02/2023265.1k

pdf
BPSD Guidance Final V2 Oct 2021 13:52 04/11/2023403.3k

pdf
Benzodiazepines Support Pack Aug16 09:10 07/10/2018655.3k

pdf
Beta Interferons in MS Commissioning Statement 09:10 07/10/201825.2k

pdf
Biliary Tract Tumours 09:10 07/10/20189.6k

pdf
Biologics Pathway for Ankylosing Spondylitis in Dorset 2018 09:10 07/10/2018368.5k

pdf
Biologics Pathway for Rheumatoid Arthritis Dec 2018 09:53 02/27/201992.2k

pdf
Biologics Pathway for Psoriatic Arthritis in Dorset 2018 09:36 10/19/2018363.6k

pdf
Biologics Decision Aid for Psoriasis 1 Updated August 2020 09:22 09/08/2020207.8k

pdf
Biologics Decision Aid for Psoriasis 2 Updated August 2020 14:54 09/07/2020171.5k

pdf
Biologics Pathway for Axial Spondyloarthritis Dec 2018 09:53 02/27/2019143.7k

pdf
Biologics Pathway for Axial Spondyloarthritis Oct 22 16:00 12/21/2022114.6k

pdf
Biologics Pathway for Axial Spondyloarthritis Feb 23 15:29 04/28/2023115.7k

pdf
Biologics Pathway for Axial Spondyloarthritis Reviewed April 21 10:40 08/24/202187.6k

pdf
Biologics Pathway for Axial Spondyloarthritis Reviewed Aug 21 14:31 10/12/202187.8k

pdf
Biologics Pathway for Psoriatic Arthritis April 21 10:42 08/24/202187.7k

pdf
Biologics Pathway for Psoriatic Arthritis Dec 2018 09:53 02/27/201992.2k

pdf
Botulinum Toxin Type A 15:15 09/16/2022496.9k

pdf
Botulinum Toxin Type A for Overactive Bladder 15:15 09/16/2022493.2k

pdf
Bowel Formulary Update 2019 12:47 07/16/2021644.3k

pub
Bowel Formulary Update 2019 11:25 05/24/20191.4M

pdf
Brain Cancer Standard Regimens 09:10 07/10/201817.8k

pdf
Brain Cancer Algorithm 09:10 07/10/201811k

pdf
Breast Adjuvant DRAFT Chemo Algorithm 09:10 07/10/201823.9k

pdf
Breast Advanced DRAFT Chemo Algorithm 09:10 07/10/201830k

pdf
Bronchodilator Delivery and Nebuliser Trial in Adults 09:11 07/10/2018438.5k

pdf
Bronchodilator Delivery and Nebuliser Trial in Adults (1) 14:32 09/16/2022438.5k

pdf
CGM FAQs V 1 20 Dec 2022 12:36 12/21/2022122.4k

pdf
CGM FAQs V 2 2 Mar 2023 13:23 03/30/2023172.3k

pdf
CHC and VTE Risk V 1 16:53 04/04/201967.5k

docx
CMDU Referral Form DCH 2022 06 06 15:43 06/29/20221.3M

pdf
CMPA Pathway March 2016 09:11 07/10/2018131.9k

pdf
COMMISSIONING STATEMENT Apixaban Vte 09:11 07/10/2018251.3k

pdf
COMMISSIONING STATEMENT FOR PRESCRIBING RIFAXIMIN (TARGAXAN®) 12:04 10/12/2020189.8k

pdf
COMMISSIONING STATEMENT ON THE USE OF PRUCALOPRIDE 12:04 10/12/2020146.6k

pdf
COMMISSIONING STATEMENT Ranibizumab TA274 09:11 07/10/2018338.2k

pdf
COMMISSIONING STATEMENT Ranibizumab TA283 09:11 07/10/2018218.5k

pdf
COMMISSIONING STATEMENT Rifaximin April 2015 09:11 07/10/2018324.1k

pdf
COMMISSIONING STATEMENT Pcsk9 09:11 07/10/2018408.9k

docx
COVID 19 Interim Guidance for Prescribers Around COPD & Asthma Rescue Packs 230320 15:38 03/23/202020.6k

docx
COVID19 Support in the Last Weeks of Life V1 4 (002) 16:25 03/27/202024.7k

pdf
CS Andexanet March 23 16:20 05/02/2023156.9k

pdf
CS Bempedoic Acid with Ezetimbe NICE TA694 15:45 04/28/2023147.4k

pdf
CS Dapagliflozin NICE TA902 July 23 14:42 08/30/2023134k

pdf
CS Ivabradine NICE TA267 15:45 04/28/2023140.7k

pdf
CS TA715 Biological DMARDs in Moderate RA 09:52 10/18/2021186.7k

pdf
CS TA715 Biological DMARDs in Moderate RA V2 10:40 12/17/2021186.7k

pdf
CS TA744 Upadacitinib in Moderate RA 10:27 12/17/2021150.3k

pdf
CS Ticagrelor NICE TA 420 & 236 15:45 04/28/2023223.6k

pdf
CS Vedolizumab for Active Crohns Disease NICE TA352 16:09 05/02/2023206.2k

pdf
CS Vedolizumab for Active Ulcerative Colitis NICE TA342 16:05 05/02/2023147.3k

pdf
CS Budesonide for Eosinophilic Oesophagitis NICE TA708 16:14 05/02/2023144.2k

pdf
CS Dapagliflozin for Heart Failure NICE TA679 Updated July 23 14:42 08/30/2023144.4k

pdf
CS Erythropoiesis Stimulating Agents for TA 323 Jan 15 09:11 07/10/2018216.8k

pdf
CS for Tofacitinib in UC NICE TA547 (1) 15:44 05/02/2023158.4k

pdf
CS for Vedolizumab in UC 09:11 07/10/2018403.4k

pdf
CS Lurasidone August 2014 09:11 07/10/2018220.9k

pdf
CS Rivaroxaban in CAD or PAD NICE TA607 15:53 04/28/2023115.9k

pdf
Calcipotriol & Betamethasone Presc Guideline July 2021 13:43 08/23/2021140.9k

pdf
Calcipotriol Betamethasasone Prescribing Guideline Revised Oct 2016 09:11 07/10/2018215.5k

pdf
Calcium Channel Blocker Feb 2015 09:11 07/10/2018350.4k

pdf
Calcium Channel Blockers for Hypertension 09:11 07/10/2018372.1k

pdf
Cannabis Oil Containing Products (unlicensed) Guidance March 21 15:18 05/10/2021105.5k

pdf
Cardiology Amiodarone A4 Leaflet June 2020 12:45 05/19/202194.9k

docx
Cardiology Antibiotics Prior to Dental Work Letter for Dorset Final; 09:55 03/21/201919.8k

pdf
Cardiology COMMISSIONING STATEMENT Rivaroxaban in ACS (1) 12:48 09/16/2022177.5k

pdf
Cardiology Commissioning Statement Inclisiran 14:55 12/17/2021272.1k

pdf
Cardiology Commissioning Statement Ivabradine July 2021 14:33 08/20/2021120.9k

pdf
Cardiology Commissioning Statement TA 599 Sodium Zirconium Cyclosilicate (1) 13:31 05/06/2022267.1k

pdf
Cardiology Commissioning Statement Dapagliflozin for Heart Failure JAn 2021 16:09 05/10/2021139k

pdf
Cardiology DOAC Review Q&A (1) 11:28 04/28/2022153.6k

pdf
Cardiology DOAC Statement Final 15:36 08/21/202097.1k

pdf
Cardiology Dorset Guidance 09:54 03/21/201970.3k

pdf
Cardiology Initiation and Transfer Form for DAPAGLIFLOZIN for the Treatment of Symptomatic Chronic Heart Failure with Reduced Ejection Fraction (1) (3) 13:03 09/16/2022199.3k

pdf
Cardiology July COMMISSIONING STATEMENT Rivaroxaban in ACS 09:11 07/10/2018495.1k

pdf
Cardiology Working Group Statement on Metolazone - 09:11 07/10/2018276.1k

pdf
Cardiology Working Group Statement on Metolazone Oct 21 14:55 12/17/2021121.6k

pdf
Cenobamate for Focal Onset Seizures TA753 Commissioning Statement 15:53 05/09/2022159.9k

pdf
Cerazette Guidance on Its Use OCT 09 09:11 07/10/201844.1k

pdf
Cervical Cancer Chemo Algorithm 09:11 07/10/201815k

pdf
Chemotherapy for Community Administration Feb 2013 09:11 07/10/201830.5k

pdf
Chickenpox and Scarlet Fever in Children GP AND URGENT CARE 220404 10:08 04/08/2022197.4k

pdf
Chronic Constipation Pathway November 2015 09:11 07/10/2018355.3k

pdf
Ciclosporin Eye Drops Information Leaflet 14:40 12/21/2022221.1k

pdf
Clexane DHPC 300617 09:11 07/10/2018239.1k

pdf
Clobetasol Neomycin Nystatin Guideline 2021 16:21 12/15/2021116.1k

docx
Clozapine SCR Letter CMHT 09:56 01/20/202040.9k

pdf
Colorectal Cancer Adjuvant DRAFT Chemo Algorithm 09:11 07/10/201818.7k

pdf
Colorectal Cancer Advanced DRAFT Chemo Algorithm 09:11 07/10/201827.6k

pdf
Comissioning Statement Mirvaso March 2015 09:11 07/10/2018244.1k

pdf
Comm Statement NICE TA 298 Amended 09:11 07/10/2018321.5k

pdf
Comm Statement NICE TA 305 Aflibercept 09:11 07/10/2018303.4k

pdf
Commisioning Statement for TNF A Inhibitors for Ankylosing Spondylitis and Axial Spondyloarthritis July 2021 11:12 08/24/2021174.9k

pdf
Commissionig Statement for Baricitinib July 2021 20:31 08/31/2021181.7k

pdf
Commissioning Statement Baricitinib 2017 09:11 07/10/2018618.7k

pdf
Commissioning Statement Bempedoic Acid with Ezetimbe July 2021 16:06 08/20/2021122.4k

pdf
Commissioning Statement Biological DMARDs in Moderate RA NICE TA715 V3 17:01 07/26/2023195.2k

pdf
Commissioning Statement Dundee Sunscreen Jan 15 09:11 07/10/2018216.7k

pdf
Commissioning Statement Filgotinib NICE TA676 April 23 16:45 07/26/2023121.9k

pdf
Commissioning Statement Filgotinib for Ulcerative Colitis 10:01 08/18/2022296.8k

pdf
Commissioning Statement Ixekizumab TA537 April 2023 14:45 07/26/2023145.1k

pdf
Commissioning Statement July 2021 Certoliz and Secukiumab for PSA 11:04 08/24/2021191.6k

pdf
Commissioning Statement Lusutrombopag 13:53 04/30/2020122.7k

pdf
Commissioning Statement N Acetylcysteine Jan 15 09:11 07/10/2018213.2k

pdf
Commissioning Statement OPEP Flutter Devices 2017 09:11 07/10/2018479.9k

pdf
Commissioning Statement Ozanimod for Ulcerative Colitis 15:36 12/21/2022156.2k

pdf
Commissioning Statement Pentosan 11:22 02/03/2020434.3k

pdf
Commissioning Statement Rimegepant For Preventing Migraine NICE TA906 14:22 10/04/2023100.4k

pdf
Commissioning Statement Romosozumab 10:01 08/18/2022181k

pdf
Commissioning Statement TA718 Ixekizumab for Axial Spondyloarthritis 14:32 10/12/2021145.5k

pdf
Commissioning Statement TA719 Secukinumab for Axial Spondyloarthritis 14:32 10/12/2021147.7k

pdf
Commissioning Statement Ticagrelor July 2021 15:18 08/20/2021222.6k

pdf
Commissioning Statement Vedolizumab for Active Crohns Disease March 2021 21:48 04/26/2021163.6k

pdf
Commissioning Statement Vedolizumab for Active Ulcerative Colitis March 21 21:48 04/26/2021161.8k

pdf
Commissioning Statement XEOMIN (BOTULINUM NEUROTOXIN TYPE A 15:45 12/18/2019141.9k

pdf
Commissioning Statement Adalimumab Dex Implant for Uveitis 2017 09:11 07/10/2018585.9k

pdf
Commissioning Statement Collagenase 2017 09:11 07/10/2018470.8k

pdf
Commissioning Statement for Apremilast for PSA July 2021 11:21 08/24/2021178.4k

pdf
Commissioning Statement for Baricitinib NICE TA466 April 23 16:56 07/26/2023173.7k

pdf
Commissioning Statement for Bimekizumab for Plaque Psoriasis NICE TA 723 09:19 12/16/2021135.9k

pdf
Commissioning Statement for Bisphosphonates Aug17 09:11 07/10/2018622.3k

pdf
Commissioning Statement for Brodalumab May 2018 09:11 07/10/2018508.6k

pdf
Commissioning Statement for Brodalumab Reviewed 2021 12:11 08/24/2021169.4k

pdf
Commissioning Statement for Empagliflozin NICE TA733 Nov 23 12:39 11/24/2023168.4k

pdf
Commissioning Statement for NICE TA345 Naloxegol and TA651 Naldemedine 12:30 02/17/2023204.1k

pdf
Commissioning Statement for PRUCALOPRIDE NICE TA211 (1) 12:30 02/17/2023149.9k

pdf
Commissioning Statement for TA375 DMARDs RA July 2021 11:34 08/24/2021148.9k

pdf
Commissioning Statement for TA375 RA April 23 14:27 08/31/2023129.3k

pdf
Commissioning Statement for Upadacitinib for Non Radiographic AS 15:18 04/28/2023151.5k

pdf
Commissioning Statement for Ustekinumab for Crohns NICE TA456 12:30 02/17/2023165.7k

pdf
Commissioning Statement for Ustekinumab for UC NICE TA633 12:30 02/17/2023236.4k

pdf
Commissioning Statement for Eulaxadoline 09:11 07/10/2018489.1k

pdf
Commissioning Statement for Golimumab NICE TA497 April 23 16:08 07/26/2023165.8k

pdf
Commissioning Statement for Tofacitinib TA543 April 23 14:53 07/26/2023120.5k

pdf
Commissioning Statement for Upadacitinib NICE TA665 April 23 16:26 07/26/2023139.8k

pdf
Commissioning Statement for Ustekinumab Crohns 12:04 10/12/2020209.4k

pdf
Commissioning Statement for Ustekinumab Crohns Sep 2017 09:11 07/10/2018613.6k

pdf
Commissioning Statement for Ustekinumab in Active PSA July 2021 10:54 08/24/2021159.1k

pdf
Commissioning Statement for Ustekinumab in Active PSA NICE TA340 April 23 V3 16:49 07/26/2023145.5k

pdf
Commissioning Statement Relugolix Estradiol Norethisterone 16:35 01/10/2023161.4k

pdf
Commissioning Statement Upadacitinib for Ulcerative Colitis Jan 23 (1) 13:00 02/17/2023342.7k

pdf
Commissioning Statement Alogliptin Aug 2014 09:11 07/10/2018315.8k

pdf
Commissioning Statement Glp 1s 09:11 07/10/2018222.5k

pdf
Commissioning Statement Cannabis Updated Dec 20 13:00 02/09/2021210.2k

pdf
Commissioning Statement Erenumab Reviewed Feb 2023 10:59 05/31/2023126k

pdf
Commissioning Statement Filgotinib Feb20 16:11 06/22/2021137.2k

pdf
Commissioning Statement Finerenone May 23 Final 14:23 07/26/2023186.5k

pdf
Commissioning Statement Fluocinolone IVI 09:58 10/17/2019105.7k

pdf
Commissioning Statement Fluocinolone IVI TA613 11:35 02/03/2020455.6k

pdf
Commissioning Statement GLP 1s March 2019 13:04 04/05/2019389.7k

pdf
Commissioning Statement Galcanezumab Reviewed Feb 2023 11:14 05/31/2023128k

pdf
Commissioning Statement Liraglutide Saxenda Weight Management Dec 2020 13:00 02/09/2021130.3k

pdf
Commissioning Statement PCSK9 July 2021 15:00 08/20/2021175.5k

pdf
Commissioning Statement TA 597 DAPAGLIFLOZIN AND Insulin 09:58 10/17/2019140.2k

pdf
Commissioning Statement TA 599 Sodium Zirconium Cyclosilicate Vs 11:19 10/17/2019171.5k

pdf
Commissioning Statement Baricitinib for Dermatitis Mar20 15:13 05/10/2021163.3k

pdf
Commissioning Statement for Ciclosporin in Dry Eye 09:11 07/10/2018268.9k

pdf
Commissioning Statement for Dundee Suncreen March 19 11:25 05/24/2019476.9k

pdf
Commissioning Statement for IQoro Feb 23 14:55 04/28/202391.6k

pdf
Commissioning Statement for Sarilumab July 2021 11:15 08/24/2021138k

pdf
Commissioning Statement for Tofacitinib in UC March 21 21:56 04/26/2021179.3k

pdf
Commissioning Statement for Avatrombopag for Primary ITP Jan 23 12:30 02/17/2023137.8k

pdf
Commissioning Statement for Biosimilar July 19 09:58 10/17/2019165.4k

pdf
Commissioning Statement for Biosimilar May 17 09:11 07/10/2018270.6k

pdf
Commissioning Statement for Biosimilar May 2023 12:52 06/30/2023132.7k

pdf
Commissioning Statement for Dexamethasone in Diabetic Macular Oedema 09:11 07/10/2018335.3k

pdf
Commissioning Statement for Infliximab, Adalimumab and Golimumab NICE TA329 (1) 12:30 02/17/2023248.4k

pdf
Commissioning Statement for Ivabradine in CHF 09:11 07/10/2018213.8k

pdf
Commissioning Statement for Liraglutide (Saxenda) 09:36 10/19/2018395.5k

pdf
Commissioning Statement for Secukinumab in Plaque Psoriasis 09:11 07/10/2018216.4k

pdf
Commissioning Statement for Tofacitinib TA543 12:54 12/21/2018394.5k

pdf
Commissioning Statement Ixekizumab Ta537 July 2018 09:36 10/19/2018503.8k

pdf
Commissioning Statement on the Use of Infliximab, Adalimumab and Golimumab 12:04 10/12/2020158.7k

pdf
Commissioning Statement Pigmanorm Updated July 18 09:36 10/19/2018383.1k

pdf
Commissioning Statement Risankizumab 12:53 09/19/2019495k

pdf
Commissioning Statement Risankizumab (1) 09:58 10/17/2019495k

pdf
Commissioning Statement Rivaroxaban in CAD or PAD 15:45 12/18/2019153.8k

pdf
Commissioning Statement Rivaroxaban in CAD or PAD July 2021 15:23 08/20/2021154k

pdf
Commissioning Statement Tildrakizumab Plaque Psoriasis Reviewed June 2021 12:23 08/24/2021129.7k

pdf
Commissioning Statement Upadacitinib Dec 2020 13:00 02/09/2021134.8k

pdf
Continence DCHS off Formulary Form 09:11 07/10/201824.3k

pdf
Copy of Dorset Christmas New Year 2022-23 Pack FINAL V2 13:31 12/23/2022205.6k

pdf
Counselling Checklist for DOACs RBH 14:11 02/28/2019133.9k

pdf
Criteria Based Access Protocol Botulinum Toxin Type A 09:11 07/10/2018496.9k

pdf
Current Peadiatric Asthma Diagram for Formulary June18 09:11 07/10/2018403k

pdf
Cynrize DHPC 270617 09:11 07/10/2018316.3k

pdf
DB DMAG Summary January 2020 Asd 16:01 02/13/2020156k

pdf
DCCG Labetalol Shortage Final 120419 16:14 04/12/2019341.8k

pdf
DFU SOC Pathway Dorset Leaflet 12:17 08/19/2022191.9k

pdf
DHC BPSD Guidance Final Version 1 1 May 2019 10:53 07/27/2021286k

pdf
DHC Guideline Medication and the Risk of Falls V2 14:01 05/15/2019299.3k

pdf
DHC Guidelines on the Use of Medication for the Managment of Behaviour That Challenges in Dementia V1 Point 1 2019 13:19 07/28/2021286k

pdf
DHSC Epipens Supply Advice Sept18 11:29 09/20/2018471.5k

pdf
DMAG Annual Report 2018 2019 12:30 11/18/2019545.1k

pdf
DMAG Annual Report 2019-2020 10:09 08/21/2020296.7k

pdf
DMAG Annual Report 2020-2021 15:29 06/22/2021260k

pdf
DMAG Annual Report 2021-2022 10:21 06/29/2022503.8k

pdf
DMAG Annual Report 2022-2023 14:06 07/27/2023439.3k

pdf
DMAG July 2022 Summary 12:48 09/16/2022218.2k

pdf
DMAG Summary 12:40 06/01/2022402.4k

pdf
DMAG Summary (1) 10:49 07/11/2022399.6k

pdf
DMAG Summary 18th May 2021 16:26 06/22/2021171.7k

pdf
DMAG Summary 20th July 2021 10:51 09/08/2021236k

pdf
DMAG Summary 23rd March 2021 16:14 05/10/2021195.6k

pdf
DMAG Summary Jan 23 14:29 02/21/2023296.2k

pdf
DMAG Summary July 2023 16:36 08/30/2023183.1k

pdf
DMAG Summary March 2023 15:21 05/03/2023254.7k

pdf
DMAG Summary May 2023 (1) 14:06 07/27/2023242.3k

pdf
DMAG Summary Nov Final 14:40 02/21/20231k

pdf
DMAG Summary Nov Final (1) 14:41 02/21/2023264.1k

pdf
DMAG Summary November 2021 Final 14:46 12/16/2021241.2k

pdf
DMAG Summary September 10:31 11/17/2022243.6k

pdf
DMAG Summary September 2023 10:53 11/02/2023163.6k

pdf
DMAG Summary 10th November 2020 11:57 12/16/2020178.1k

pdf
DMAG Summary 14th July 2020 10:31 08/21/2020199.9k

pdf
DMAG Summary 15th September 2020 14:58 10/12/2020155k

docx
DMAG Summary Jan 2019 13:07 03/29/201979.9k

pdf
DMAG Summary July 2019 13:21 09/19/2019416.7k

pdf
DMAG Summary March 2018 09:11 07/10/2018513.8k

pdf
DMAG Summary March 2019 12:14 11/18/2019414.8k

pdf
DMAG Summary May 2019 MT 12:14 11/18/2019226.8k

pdf
DMAG Summary November 2019 13:41 12/19/2019168.6k

pdf
DMAG Summary September 2019 09:40 10/24/2019171.1k

pub
DOAC Alert Card (2) 10:40 10/18/2018106k

pdf
DOAC Review Q&A (2) (1) 13:27 05/06/2022153.9k

pdf
DOAC Review QA (1) (3) 10:34 05/24/2022207.5k

pdf
DOAC Checklist Oct 2022 Version 10 15:49 02/13/2023248.1k

pdf
DUAL ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROME 09:11 07/10/2018275.6k

pdf
Dapagliflozin for CKD Commissioning Statement March 2022 DMAG Final 16:53 06/15/2022165.4k

pdf
Dec 2018 KTTT 12:21 12/28/2018575.7k

pdf
Degarelix Commissioning Statement 09:11 07/10/2018198.7k

pdf
Delaying Menstruation During Holidays 09:11 07/10/2018193.7k

pdf
Deprescribing Bisphosphonates 14:50 12/21/2022234.5k

pdf
Derm 2023 CS Pigmanorm 14:18 03/28/202394.1k

pdf
Dermatology CS Apremilast in Moderate Severe Plaque Psoriasis 16:01 12/22/2022158.1k

pdf
Dermatology CS Baricitinib for Dermatitis April 23 12:01 07/20/2023196.1k

pdf
Dermatology CS Certolizumab TA574 Psoriasis 16:08 12/22/2022122k

pdf
Dermatology CS Dundee Sunscreen 2022 09:54 03/30/2023190.7k

pdf
Dermatology CS Dupilumab Moderate Severe Atopic Dermatitis 15:55 12/22/2022151.8k

pdf
Dermatology CS Ixekizumab Moderate Severe Plaque Psoriasis (2) 16:13 12/22/2022119.5k

pdf
Dermatology CS Omalizumab in Chronic Spontaneous Urticaria 15:34 12/22/2022117.5k

pdf
Dermatology CS Risankizumab Moderate Severe Plaque Psoriasis (1) 15:41 12/22/2022118.8k

pdf
Dermatology CS Secukinumab in Moderate Severe Plaque Psoriasis 15:50 12/22/2022144.3k

pdf
Dermatology CS for Bimekizumab for Plaque Psoriasis April 23 12:58 07/20/2023161.6k

pdf
Dermatology CS Tildrakizumab for Plaque Psoriasis April 23 (1) 12:18 07/20/2023123.4k

pdf
Diabetes Access to CCGM and IsCGM Following Publication of NICE Guidance V4 (2) 14:09 10/25/202297k

pdf
Diabetes Appendix 3 Draft Guidance for Insulin Start in Type 2 Diabetes 14:25 12/14/2020130.2k

pdf
Diabetes Appendix 4 Draft Growth Hormone in Children and Adults Commissioning Statement Vs Edits (002) 14:25 12/14/2020156.6k

pdf
Diabetes Blood Glucose Test Strips Formulary Information 3 Mar 2023 15:20 05/02/2023181.2k

pdf
Diabetes Blood Glucose Test Strips Formulary Information 3 Mar 2023 (1) 17:44 05/02/2023181.2k

pdf
Diabetes CGM FAQs V 2 1 Sept 23 10:44 10/23/2023164.7k

pdf
Diabetes Freestlye Libre Children Comissioning Statement1018 12:00 11/30/2018511.2k

pdf
Diabetes GLP 1s Commissioning Statement Dec 2020 22:05 04/26/2021143.7k

pdf
Diabetes GLP 1s Commissioning Statement Nov 2019 15:45 12/18/2019144.8k

pdf
Diabetes GLP 1s Commissioning Statement Nov 2021 15:09 12/16/2021145.6k

pdf
Diabetes GLP 1s SCG Dec 2020 22:05 04/26/2021344.1k

pdf
Diabetes GLP 1s SCG July 2021 11:35 08/23/2021343.2k

pdf
Diabetes GLP1 Guidance for Primary Care 21:15 04/26/2021150k

pdf
Diabetes Local Guidance for the Safe Use of SGLT2i (1) 14:47 04/28/2023305.2k

pdf
Diabetes Local Guidance for the Safe Use of SGLT2s Reviewed Dec 2020 21:28 04/26/202195.3k

pdf
Diabetes SCG GLP 1 MArch 2019 13:04 04/05/2019641.9k

pdf
Diabetes Vit D Guidelines V5 (1) 13:51 04/18/2019617k

pdf
Diabetes and Endo Shared Care Guideline Alkindi March 2019 13:04 04/05/2019585.3k

pdf
Diabetes Foot Wound Care Formulary and Anti Microbial Management Comments Review (003) 15:40 10/13/2020232.1k

pdf
Diabetes Foot Wound Care Formulary and Anti Microbial Management March 2023 16:12 04/18/2023229.2k

pdf
Diabeties Freestlye Libre Comissioning Statement 0419 March 29 21:38 04/26/2021143.6k

pdf
Diamorphine Primary Care Communication May 2019 12:31 05/24/2019121.3k

pdf
Digoxin Policy Feb 2021 14:27 02/22/2021257.1k

pdf
Dilantin Infatab DHCP Letter CCC (Final Version) 11:57 05/07/2019172.7k

PDF
Dilantin PIL 12:19 05/08/2019254.9k

pdf
Dilantin PIL and Monograph 16:47 06/06/2019438.1k

pdf
Direct Oral Anticoagulants 11:51 02/07/2020222.9k

docx
Direct Oral Anticoagulants AB V3 March 19 09:16 03/29/201976.3k

PDF
Discontinuation of 40K Patient Letter 10:41 04/01/2019462.7k

pdf
Dorset Asthma Prescribing Guide for CYP Final 11:33 01/06/2023361.6k

pdf
Dorset Asthma Prescribing Guide for CYP Final V 2 May 23 13:41 08/23/2023376.7k

pdf
Dorset Biologic RA Pathway V2 May 2021 16:06 06/22/2021124.9k

pdf
Dorset Biologics Pathway for Psoriatic Arthritis Sept 22 12:40 10/18/2022105k

pdf
Dorset Bowel Continence Formulary Edition 4 Booklet for Self Printing 2022 12:30 02/17/2023491k

pdf
Dorset Bowel Continence Formulary Edition 4 Final Version 2022 12:30 02/17/2023498.3k

pdf
Dorset CCG Prescribing for Overseas Travel V4 June17 08:34 10/04/2018339.4k

pdf
Dorset CCG Prescribing for Overseas Travel V4 1 April 2021 09:53 09/01/2021238.7k

pdf
Dorset COPD Guideline 2022 V4 Post DMAG Additions (002) 15:54 12/21/2022435k

pdf
Dorset COPD Treatment Guideline Jul2017 09:11 07/10/2018473.1k

pdf
Dorset COPD Treatment Guideline June 2018 09:11 07/10/2018454.1k

pdf
Dorset COPD Treatment Guideline May 2019 12:28 08/02/2019497.1k

pdf
Dorset Green Inhaler Guidance DMAG Version V2 09:43 06/29/20221M

pdf
Dorset Green Inhaler Guidance DMAG Version V2 (1) 14:32 09/16/20221M

pdf
Dorset Green Inhaler Guidance DMAG Version V2 (2) 14:52 09/16/20221M

pdf
Dorset Opioid Resource Pack FINAL Sept 2020 08:50 09/17/20201.6M

pdf
Dorset Pathway for Bisphosphonates in Post Menopausal Women 09:11 07/10/2018326.5k

pdf
Dorset Primary and Secondary Management of Osteoporosis Guidance 09:11 07/10/2018438.9k

docx
Dorset Shared Care Guideline TEMPLATE Jan 23 (1) 12:23 03/21/202360.3k

pdf
Dorset Skin Tear Pathway 15:30 01/31/2019234.1k

pdf
Dorset Skin Tear Pathway Feb 2019 10:01 02/18/2019234.6k

pdf
Dorset Vitamin and Mineral Supplementation Guidelines 2022 16:20 01/27/2023133.6k

pdf
Dorset Diabetes Foot Ulcer Stands of Care 10:42 09/02/2020341.1k

pdf
Dorset Guidelines for the Use of Digifab 09:11 07/10/2018535.1k

pdf
Dorset Healthcare Medicines Team Leaflet 042019 09:40 04/02/2019477.9k

docx
Dorset Imms Incident Reporting Form FINAL V1 0 11:26 05/12/202056.7k

pdf
Dorset Version SCP Amiodarone for Patients Within Adult Services (2) 11:49 05/17/2023383.3k

pdf
Dorset Version SCP Dronedarone for Patients in Adult Services (3) 11:49 05/17/2023390.2k

pdf
Doxazosin Conversion FINAL2015 10:10 10/05/2018162k

pdf
Dry Eye Prescribing Guidelines 09:09 05/04/2020240.2k

pdf
Dry Eye Pathway Final 09:11 07/10/2018319.5k

pdf
EMA Recommendation to Restrict Strontium Usage 09:11 07/10/201877.4k

pdf
ENC 57g IN USE EXPIRY OF EYE DROPS IN A SECONDARY CARE SETTING May 2019 Approved 16:29 07/31/2019253.4k

docx
ENC Cv Communication for Care Homes 09:11 07/10/201815k

pdf
ENC D Regulation 28 Letter 15 12 17 07519 09:11 07/10/2018213.5k

pdf
ENC Giii FCP Pathway Final 09:11 07/10/2018284k

pdf
ENC I Accolate Discontinuation Letter Others Sep 17 09:11 07/10/2018107.2k

pdf
ERD In Focus Final 09:21 07/19/2018214.4k

pdf
EllaOne Guidance March 2010 09:11 07/10/201830k

pdf
Eltrombopag 09:11 07/10/2018281.6k

pdf
Emollient Patient Letter Final 09:21 07/19/2018303.4k

pdf
Emollient Comparison Chart 09:11 07/10/2018558.7k

pdf
Emollient Comparison Chart Final 09:21 07/19/2018385.6k

pdf
Emollient Comparison Chart 2021 12:53 08/24/2021242k

pdf
Enc Oi Urinary Incontinence Product Booklet Oct16GB 2 09:11 07/10/2018641.9k

pdf
Enclosure D Rivaroxaban Commissioning Statement 09:11 07/10/2018111.3k

pdf
Endocrine Cancer DRAFT Standard Regimen List 09:11 07/10/201813.2k

pdf
End of Flu 1819 CAS Altert 12:19 05/08/2019267.5k

pdf
Endometrial Cancer Chemo Algorithm 09:11 07/10/201812.3k

PDF
Epanutin Infatabs PIL 12:19 05/08/201953.2k

pdf
Epanutin PIL and SPC 16:47 06/06/2019301.5k

pdf
EpiPen 150 Microgram Validation Protocol Final (003) 12:15 10/19/2018469.7k

PDF
EpiPen Information for Pharmaciessg BW 08:36 12/04/2018350.9k

pdf
Epipen Letter to Patients 151018 09:59 10/16/2018316.5k

pdf
Epipen Revised Supply Alert 151018 09:55 10/16/2018199.5k

pdf
Erectile Dysfunction Pathway Nov 11 DHUFT 09:11 07/10/2018131.3k

pdf
Evra Guideline to Support Prescribing Jan 15 09:11 07/10/2018516.9k

pdf
Eye Drop Dispensers Guidance 09:11 07/10/2018190.8k

pdf
Eye Drop Conversion Table 09:11 07/10/2018245.5k

pdf
FAQ Palliative Care V1 300420 16:11 01/21/2021280.1k

pdf
FWG 2022 CS (NICE TA283) Ranibizumab Macular Oedema RVO 16:36 12/22/2022120.6k

pdf
FWG 2022 CS (NICE TA298) Ranibizumab Choroidal Neovascularization 12:23 12/23/2022118k

pdf
FWG 2022 CS (NICE TA305) Aflibercept for Visual Impairment Sec to CRVO 11:03 12/23/202297.1k

pdf
FWG 2022 CS (NICE TA346) Aflibercept in Diabetic Macular Oedema 11:10 12/23/2022149.4k

pdf
FWG 2022 CS (NICE TA460) Adalimumab and Dexamethasone Implant Non Infectious Uveitis 10:48 12/23/2022186.3k

pdf
FWG 2022 CS (NICE TA486) Aflibercept for Choroidal Neovascularisation 10:51 12/23/202295.6k

pdf
FWG 2022 CS Botulinum A Xeomin 12:04 12/23/2022147.6k

pdf
FWG 2022 CS Fluocinolone in Diab Mac Oedema After Prev Therapy 12:13 12/23/2022125.7k

pdf
FWG 2022 CS Ocriplasmin 12:18 12/23/2022120.2k

pdf
FWG CS Lusutombopag in Thrombocytopenia in Liver Disease 16:28 12/22/2022116.8k

pdf
Falls Poster V1 13:36 09/02/2019170.5k

pdf
Faricimab for DMO Commissioning Statement NICE TA 799 10:01 08/18/2022180.6k

pdf
Faricimab for Wet AMD Commissioning Statement NICE TA800 10:01 08/18/2022182.5k

pdf
Feb19 Anti Microbial Product Infortion for the Treatment of Infectedcritically Colonised Wounds 13:40 02/20/2019139.3k

pdf
Feb 19v2 Pan Dorset Wound Care 13:32 02/20/2019229.6k

pdf
Feb 2023 KTTT 09:31 03/02/2023186.4k

docx
Feedback Form Updated V2 12:24 03/16/202331.6k

pdf
Fentanyl IR Comissioning Statement 2020 13:53 04/30/2020223.1k

pdf
Final AAI QAs for Pharmacies and Dispensing Practices 16 10 2018 12:15 10/19/2018676.9k

pdf
Final DTC Draft Policy for the Use and Supply of Digoxin Specific Antibody (DigiFab) V3 Jun 2020 (HB) 14:27 02/22/2021291.4k

pdf
Final Formulary Schematic Diagram Sep18 15:14 01/02/2019367.8k

pdf
Final Guidelines for the Prescribing of Stoma Additional Products in Primary Care January 2020 14:22 02/28/2020619.7k

pdf
Final Consensus Statement for the Choice of Bisphosphonate to Use for TA 160 161 09:11 07/10/201822.4k

pdf
Final with Signature Epanutin to Dilantin DHCP Letter 05 06 19 (1) 16:47 06/06/2019158.6k

pdf
Flex 2006 09:11 07/10/2018214.2k

docx
FluOOS Claim NHSnolist V3 09:22 10/12/201840.9k

docx
FluOOS Claim NHSnolist V3 (1) 16:27 10/02/201940.9k

docx
FluOOS Claim NHSnolist V3 (3) 18:03 10/06/202143k

docx
FluOOS Community P'cy Claim NHS D V3 Review Aug 24 14:14 08/15/202323.2k

doc
FluOOS Invoice Claim V (3) 18:03 10/06/202136k

doc
FluOOS Invoice Claim V2 09:22 10/12/201836k

doc
FluOOS Invoice Claim V2 (1) 16:27 10/02/201936k

docx
FluOOS Invoice Template NHS Dorset ICS V 2 Aug23 14:14 08/15/202320.5k

docx
FluOOS PSD 09:22 10/12/201841.1k

docx
FluOOS PSD (1) 16:28 10/02/201941.5k

docx
FluOOS PSD (2) 12:59 08/24/202042.8k

docx
FluOOS PSD (3) 18:03 10/06/202143k

docx
FluOOS PSD Proforma V3 Aug 23 14:14 08/15/202322.9k

pdf
FluOOS Protocol 18-19 09:22 10/12/2018561.5k

docx
FluOOS Protocol NHS Dorset V3 Aug 23 16:02 08/15/202370.8k

pdf
FluOOS Protocol V5 19-20 16:28 10/02/2019563.5k

pdf
FluOOS Protocol V5 20-21 12:59 08/24/2020254.1k

pdf
FluOOS Protocol V5 21-22 18:03 10/06/2021241.2k

pdf
Fluocinolone TA301 Commissioning Statement 09:11 07/10/2018443.6k

pdf
Focus on Preconception Care for Women with Epilepsy 09:11 07/10/2018317.8k

pdf
Formulary Appendix 8 Community Pharmacy Palliative Care Drugs List April 2020 21:08 04/26/2021132.3k

pdf
Formulary Continence Desmopressin (1) 12:40 06/01/2022187.7k

pdf
Formulary Guidelines for the Prescribing of Stoma Additional Products in PC Oct 21 10:52 04/29/2022291.7k

docx
Formulary Proposal Form Jan 23 14:47 08/17/2023112.4k

docx
Formulary Proposal Form June 2020 10:09 08/21/202074.9k

docx
Formulary Proposal Form March 2018 FINAL 09:40 07/19/201881.5k

doc
Formulary Proposal Form September 2018 11:10 12/12/2018230.5k

pdf
Formulary Proposal Form September 2018 17:06 11/14/2018733.7k

docx
Formulary Proposal Form V1 2 17:23 08/31/202176k

docx
Formulary Proposal Form V1 5 June 16:56 06/29/2022127.2k

docx
Formulary Proposal Updated Form June 2020 (002) with Amended UHD Details January 2021 15:05 01/18/202174.7k

pdf
Formulary Schematic Diagram Nov 21 09:26 12/16/2021106.1k

pdf
Formulary Decision Making Criteria 17:23 08/31/2021106.5k

pdf
Formulary for Infant Formula Dec17 09:11 07/10/2018514.1k

pdf
Fortacin Comissioning Statement March 17 09:11 07/10/2018343.5k

pdf
Freestlye Libre Comissioning Statement 09:11 07/10/2018359.2k

pdf
Freestlye Libre Comissioning Statement 0419 March 29 16:47 03/29/2019110.6k

pdf
Freestlye Libre Comissioning Statement0818 15:23 08/24/2018506.8k

pdf
Fremanezumab Commissioning Statement July 20 V1 15:36 07/30/2020125.6k

pdf
Fremanezumab for Migraine TA764 Commissioning Statement 15:18 05/09/2022125.3k

docx
GF Changes Leaflet for Patients Approved 12:06 12/21/201864.3k

pdf
GF Changes Leaflet for Patients Approved 12:12 12/21/2018382.3k

pdf
GUIDANCE ON PRESCRIBING OF CONTRACEPTIVES TO GIRLS UNDER 16 YEARS 16:04 10/15/2020358k

pdf
GUIDELINES FOR THE PHARMACOLOGICAL MANAGEMENT OF DIABETIC NEUROPATHIC PAIN IN PRIMARY CARE 09:11 07/10/2018151.2k

pdf
Gabapentinoids 13:51 09/20/2018514.9k

pdf
Gastro CS for Vedolizumab in Crohns 09:11 07/10/2018427.9k

pdf
Gastro Intestinal Stromal Algorithm 09:11 07/10/20189.8k

pdf
Gastroenterology Commissioning Statement NICE TA345 Naloxegol and TA651 Naldemedine 15:33 12/14/2020197.2k

pdf
Gastroenterology Faecal Calprotectin Pathway (National NICE Approved) 15:26 12/14/2020242k

docx
Gastroenterology Mesalazine Asacol to Octasa Patient Switch Letter 16:18 12/14/202023.9k

pdf
Gastroenterology Mesalazine MR IN Focus 16:21 12/14/2020167.3k

pdf
Gastroenterology Treatment of Constipation in Adults Final 16:12 12/14/2020270.5k

pdf
Gastroenterology Commissioning Statement for Linaclotide 13:53 07/06/2021184.3k

pdf
Glucose Management in Type 2 Diabetes Jan15 13:10 10/03/2019317.3k

pdf
Great Green Respiratory Care Poster 13:36 04/03/2023110.4k

pdf
Guidance on the Use of Antipsychotics for Conditions Other than Schizophrenia 09:11 07/10/201836.2k

pdf
Guideline for Eflornithine 2021 12:43 08/24/2021151.9k

pdf
Guideline for Paracetamol Use RBCH 09:11 07/10/201869.4k

pdf
Guidelines for the Prescribing of Stoma Additional Products in Primary Care Final 09:11 07/10/2018294.1k

pdf
Guidelines for the Prescribing of Stoma Additional Products in Primary Care May 18 Approved 09:11 07/10/2018625.1k

pdf
Guidelines for the Prescribing of Stoma Additional Products in Primary Care Updated SEP 20 09:11 10/01/2020296.1k

pdf
Gynae Cancer Standard Regimens 09:11 07/10/201825.9k

pdf
HRT PPC Advice 09:09 03/30/2023127.8k

pdf
HRT PPC Advice (2) 14:31 03/30/2023127.7k

pdf
HRT Communications 23 08 20191 10:07 09/02/2019581k

pdf
HSC Impotence SLS 09:11 07/10/2018280.8k

pdf
Haematology Standard Regimens 09:11 07/10/201896.3k

pdf
H and N Palliative Chemo Algorithm 09:11 07/10/201812.6k

pdf
H and N Cancer Standard Regimens 09:11 07/10/201820.2k

pdf
H and N Chemoradiotherapy Chemo Algorithm 09:11 07/10/201816.4k

docx
High Cost PPI in Focus 0519 09:14 05/16/201945.7k

pdf
How to Make the Most of Your Meals 09:11 07/10/2018147.9k

docx
How to Upload a Document to the Dorset Formulary 18102021 V1 12:43 10/18/202111.7k

pdf
How to Upload a Document to the Dorset Formulary 18102021 V1 12:43 10/18/202131.2k

pdf
IBD High Cost Drugs Pathway V3 Including Ozanimod and Upadacitinib Feb 23 MT May 23 15:12 05/03/2023551k

pdf
ICD AssessmentTool 09:11 07/10/2018109.1k

pdf
ICD AssessmentTool (002) 09:59 10/12/2018109.1k

pdf
IL 6 Inhibitors for Patients Hospitalised Due to COVID 19 Nov 22 13:52 11/30/2022248.4k

pdf
IN 227 Dementia Pathway 2022 V2 (002) 14:54 12/21/2022168.1k

pdf
INCLISIRAN FAQ Final Version 05 05 2023 15:44 05/10/2023109.3k

pdf
Immunosuppressant Prescribing Information Update Jan 2015 09:11 07/10/2018190.5k

pdf
In Focus BGTS Final May 2020 10:23 08/19/2020197.4k

pdf
In Focus BGTS Final September 2017 Updated Mw 09:21 07/19/2018635.4k

pdf
In Focus Fibrates July 23 15:15 09/15/2023164.2k

pdf
In Focus Pregabalin Final 09:21 07/19/2018495.4k

pdf
In Focus Quetiapine XL Final 09:21 07/19/2018213.8k

pdf
In Focus Quinine V3 July 23 15:14 09/15/2023164.8k

pdf
In Focus ACB 14:53 02/15/2019362.6k

docx
In Focus Bath Emollients 2020 Final 13:55 07/17/202044.8k

pdf
In Focus Bath Emollients 2020 Final 11:16 07/23/2020143.8k

pdf
In Focus DAMN 14:53 02/15/2019361.1k

pdf
In Focus PERT 14:41 10/12/2020150.2k

pdf
In Focus PPI March 21 15:29 05/10/2021302.1k

pdf
In Focus PPI Deprescribing 14:54 02/15/2019677.5k

pdf
In Focus U I DeprescribingGuide 10:43 04/01/2022139.1k

pdf
In Focus Epact 2 Polypharmacy Comparators 14:53 02/15/2019361.5k

pdf
In Use Safety of Intravenous Magnesium Sulfate Oct2018vs2 11:09 11/13/2018559.6k

pdf
Ixekizumab Commissioning Statement for TA442 09:11 07/10/2018369.8k

docx
JWFG Nonformulary Rationale Form V2 16:25 03/16/202332.3k

pdf
JWFWFG Appendix 1 Pan Dorset Wound Care Formulary 16:42 12/14/202073.1k

pdf
JWFWFG Appendix 1 Pan Dorset Wound Care Formulary (1) 16:24 12/16/202073.6k

docx
JWFWG Appendix 2 Skin Barrier Wound Care Product Request V6 16:37 12/14/202038.8k

docx
JWFWG Appendix 2 Skin Barrier Wound Care Product Request V6 (1) 16:24 12/16/202039.1k

pdf
JWFWG Dorset Skin Tear Pathway Oct21 Version (3) 14:12 05/06/2022417.4k

pdf
JWFWG Napkin Associated Dermatitis 15:57 05/09/2022470k

pdf
JWFWG Pan Dorset Moisture Pathway 14:30 05/06/2022250.6k

pdf
Jan 2019 KTTT 10:43 01/28/2019454.2k

pdf
LFPSE Comms 03 03 23 09:09 03/30/202395.6k

pdf
LPC LMC MDS Guidance 2018 08:46 08/23/2018493.1k

pdf
Leg Cramps Leaflet Sept 23 12:10 09/27/2023199.2k

docx
Letter for Non Formulary Drugs 13:21 09/03/202014.4k

PDF
Letter of Temporary Cessation of Epanutin Oral Suspension FINAL (002) 13:44 10/23/201859.9k

docx
Letter to Hospital to Decline Prescribing Jan2017 NHSD 16:03 02/01/202341.8k

docx
Letter to Hospital to Decline Prescribing May 2023 14:58 05/18/202336.1k

pdf
Liothyronine SCG March 2019 13:04 04/05/2019489.4k

pdf
Liothyronine Statement for DMAG Mar 21 2017 NEW 09:11 07/10/2018178.5k

pdf
Local Guidance for the Safe Use of SGLT2s Updated July 2018 14:52 10/04/2018321.6k

pdf
Local Guidance for the Safe Use of SGLT2s Updated July 2018 (1) 09:36 10/19/2018321.6k

pdf
Long Term Bisphosphonate Therapy Info Sheet Prof Thompson 2012 09:11 07/10/2018252.3k

pdf
Lung Cancer Standard Regimens 09:11 07/10/201839.6k

docx
MASTER Re Formatted Formulary Proposal Form Feb 2019 11:41 02/19/201988.1k

docx
MASTER Re Formatted Formulary Proposal Form September 2018 Hb 12:17 02/11/201987.1k

pdf
MIG Statement on Oral Anti Emetics 09:11 07/10/2018421.6k

pdf
MSN 2023 068 Atomoxetine 40mg and 60mg Capsules 14:18 08/11/2023145.3k

pdf
Management of Fibromyalgia 2017 09:11 07/10/2018721.8k

pdf
Management of Neuropathic Pain Final Aug 09 09:11 07/10/201829.4k

pdf
Management of Hyperhidrosis Guidance July 2021 12:57 08/23/2021311.7k

pdf
Management of Hyperhidrosis Guidance June 18 09:11 07/10/2018607k

pdf
Management of Hypomagnesaemia in Primary Care 09:11 07/10/2018440k

pdf
Management of Hypomagnesaemia in Primary Care (1) 12:04 10/12/2020197.9k

pdf
Management of Hypomagnesaemia in Primary Care Jan 23 Copy 14:09 02/17/2023185.9k

docx
Managing Vitamin B12 Injections During COVID (002) 09:20 03/31/202041.7k

pdf
March 2023 KTTT 15:10 03/29/2023288.4k

pdf
Medical Management of Glucocorticoid Induced Osteoporosis 2012 09:11 07/10/2018252.3k

pdf
Medical Management of Glucocorticoid Induced Osteoporosis March 2020 14:58 07/13/2020218.9k

pdf
Medical Management of Glucocorticoid Induced Osteoporosis March 2020 (1) 13:02 06/03/2021219.6k

pdf
Meds Shortage Guidance Jun18 09:56 12/07/201883.5k

pdf
Memory Gateway Pathway 09:11 07/10/2018332.7k

pdf
Mental Health Discontinuation of Fluphenazine Decanoate 09:36 10/19/2018379.4k

docx
Mental Health Managing Trimipramine 09:11 07/10/201821.3k

docx
Mental Health Managing Trimipramine Final March 21 10:33 06/10/202152.3k

pdf
Mental Health Shared Care AChEI Update Nov 2018 14:24 12/28/2018670.3k

pdf
Mental Health Primary Care Protocols Depression Final 2018 09:11 07/10/2018255.1k

pdf
Mental Health Primary Care Protocols Anxiety FINAL 2018 09:11 07/10/2018177.1k

pdf
Mental Health Shared Care ADHD Adult 2018 14:24 12/28/2018594.6k

pdf
Mesothelioma 09:11 07/10/201815.2k

pdf
Methotrexate Interaction Poster 2019 11:51 12/06/2019640k

pdf
Microgynon HCP 12:31 05/24/2019154.4k

pdf
Microgynon Ovranette Comms May 2019 12:32 05/24/2019125.6k

pdf
NEW Commissioning Statement Ticagrelor 2017 09:11 07/10/2018319.5k

pdf
NHS DORSET CLINICAL COMMISSIONING GROUP POSITION STATEMENT ON ORAL ANTICOAGULANTS IN ATRIAL FIBRILLATION 09:11 07/10/2018603.7k

pdf
NICE Biologics Pathway for Psoriatic Arthritis March 22 16:07 05/09/202291.6k

pdf
NICE Commissioning Statement Guselkumab PsA with Psoriasis 2021 17:20 08/31/2021126k

pdf
NICE Empagliflozin Commissioning Statement 09:19 07/13/2022253.4k

pdf
NICE Empagliflozin Commissioning Statement (1) 14:32 09/16/2022253.4k

docx
NICE Empagliflozin Initiation Form and Transfer of Prescribing 16:46 06/29/202255k

pdf
NICE TA 265 Denosumab 09:11 07/10/2018233.2k

pdf
NICE TA 266 Mannitol 09:11 07/10/2018403.7k

pdf
NICE TA 276 Colistimethate Sodium and Tobramycin Dry Powders 09:11 07/10/2018277.3k

pdf
NICE TA 358 Tolvaptan Commissioning Statement 09:11 07/10/2018219.1k

pdf
NICE TA 358 Tolvaptan Commissioning Statement Reviewed July 21 16:09 10/12/2021115.5k

pdf
NICE TA 383 TNF Alpha Inhibitors for AS and Non Radiographic Axial Spondyloarthritis Commissioning Statement 09:11 07/10/2018343.4k

pdf
NICE TA 803 CS Risankizumab for Psoriatic Arthritis 12:49 10/18/2022131.8k

pdf
NICE TA 805 CS Icosapent Ethyl 09:43 10/12/2022164.8k

pdf
NICE TA 807 CS Roxadustat for Treating Symptomatic Anaemia in Chronic Kidney Disease 09:43 10/12/2022119k

pdf
NICE TA 814 CS for Biologics in Dermatitis 10:21 11/07/2022152.3k

pdf
NICE TA 815 CS Guselkumab for Psoriatic Arthritis 13:40 10/19/2022129.3k

pdf
NICE TA 820 CS Brolucizumab for Treating Diabetic Macular Oedema 11:32 10/17/2022237.3k

pdf
NICE TA Commissioning Statement Andexanet May 2021 10:48 07/27/2021139.5k

pdf
NICE Upadacitinib for Active Psoriatic Arthritis NICE TA768 Commissioning Statement 15:22 05/09/2022133.5k

pdf
NICE Commissioning Statement Budesonide for Eosinophilic Oesophagitis 2021 15:28 08/24/2021145.3k

doc
NMP Change of Circ Sept18 08:59 12/14/2021133k

pdf
NOACs in a Nutshell 09:11 07/10/2018225.3k

pdf
NOTIFICATION OF HIGH COST EXCLUDED DRUGS June 2016 09:23 07/19/2018199.4k

doc
NOTIFICATION OF HIGH COST EXCLUDED Drugs 2018 09:30 07/19/201841k

pdf
NSAID Info Prescribers 0519 09:14 05/16/2019651.3k

pdf
NSCLC CRT 09:11 07/10/201810.5k

pdf
NSCLC Palliative 09:11 07/10/201819.7k

pdf
Nalmefene COMMISSIONING STATEMENT Jan 2015 09:11 07/10/2018339.4k

pdf
National Hydroxycarbamide Shared Care Protocol DMAG Approved Jan 23 12:30 02/17/2023345.3k

pdf
Nebuliser Pathway Pdf V2 May 23 14:21 08/23/2023377.4k

doc
New Proposal Form February 2015 09:23 07/19/2018163k

pdf
Nifedipine Memo 13 Feb 2019 (1) 12:52 02/18/201993.1k

pdf
Non Formulary Rationale Form2 2019 15:27 01/31/201913.2k

pdf
NonFormulary Rational Form2 Edit 16:48 05/30/201952.7k

pdf
ONS QA April 2021 14:09 10/14/2021149.4k

pdf
OTC GP Practice Letter 09:17 03/25/2019265.5k

pdf
Ocriplasmin Comissioning Statement 09:11 07/10/2018283.9k

pdf
Oct 2018 KTTT 15:01 11/01/2018457.1k

pdf
Oesophageal Cancers 09:11 07/10/201814.1k

pdf
Oesophagogastric 09:11 07/10/201815.6k

pdf
Omalizumab Commissioning Statement NICE TA 339 Updated 2018 09:36 10/19/2018531.2k

pdf
Opioid Substitute COMMISSIONING STATEMENT 09:11 07/10/2018358.1k

pdf
Osteoporosis Commissioning Statement Bisphosphonates TA464 May 2021 16:11 08/23/2021207.3k

pdf
Osteoporosis Denosumab Guideline Nov 21 09:38 12/10/2021204.7k

pdf
Osteoporosis Denosumab Guideline Nov 21 (1) 11:06 01/27/2023204.7k

pdf
Osteoporosis Fracture Management Pathway from Nishan De Fonseka DME Consultant POOLE (003) 16:21 08/23/2021205.2k

pdf
Osteoporosis Guidance 13:03 10/26/2018447.9k

pdf
Ovarian Cancer Chemo Algorithm 09:11 07/10/201816.6k

pdf
PALIPERIDONE LONG ACTING INJECTION Guidelines 2013 09:11 07/10/2018237.1k

pdf
PATHWAY FOR PRESCRIBING ORAL NUTRITIONAL SUPPLEMENTS IN DORSET CCG A4 09:11 07/10/2018507k

pdf
PATHWAY FOR PRESCRIBING ORAL NUTRITIONAL SUPPLEMENTS IN DORSET CCG A4 Updated MUST Link 161221 18:28 12/16/2021198.8k

pdf
PATHWAY FOR PRESCRIBING ORAL NUTRITIONAL SUPPLEMENTS IN DORSET CCG April 2021 11:30 09/05/2021198k

pdf
PATHWAY FOR PRESCRIBING ORAL NUTRITIONAL SUPPLEMENTS IN DORSET ICB APRIL 23 16:35 05/18/2023253.7k

pdf
PCDS GLP 1 RA Shortage Statement 1 16:22 10/12/202296.1k

pdf
PHE Guidance for Phased Re Introduction of Hepatitis B Vaccine for Lower Priority Groups 2018 09:11 07/10/2018247k

pdf
PMC Flyer Subscribers 15:49 05/02/2019124.5k

pdf
PRN00058 Group a Streptococcus in Children Interim Clinical Guidance December 2022 09:49 12/12/2022267.3k

pdf
Paediatric Liquid Medicines Standardised Concentrations Sep 20 Version 1 2 11:56 12/16/2020473.9k

pdf
Pain Management Guidance 2019 13:09 09/26/20191.8M

pdf
Palforzia for Peanut Allergy NICE TA 769 Commissioning Statement 15:27 05/09/2022130.5k

pdf
Palliative Care Drug Pharmacies Updated Dec 2022 09:52 12/06/2022139.1k

pdf
Palliative Care Handbook 7thEdition Oct2010 09:11 07/10/2018384.3k

pdf
Pan Dorset Moisture Pathway 09:11 07/10/201855.4k

pdf
Pan Dorset Wound Care Formulary 2017 2018 FINAL 09:11 07/10/2018127k

pdf
Pan Dorset Wound Care by Tissue Type March 2023 16:12 04/18/2023113.3k

pdf
Pan College Guidance Document on Valproate Use V2 1 09:46 04/28/20221.4M

pdf
PancreaticEnzymeReplacementTherapy (A Guide to Taking) 12:04 10/12/20201k

pdf
PancreaticEnzymeReplacementTherapy (A Guide to Taking) (1) 12:26 10/12/202050.5k

pdf
Pancreatic Cancer 09:11 07/10/201815.1k

pdf
Parkinson's Disease Guideline Nov 20 15:09 12/14/2020314k

pdf
Pathway for Taking a Drug through the Formulary Process 17:23 08/31/202160.2k

pdf
Patient Information DiamorphineFINAL 09:25 08/14/2018255k

pdf
Patient Leaflet Freestyle May 2018 13:14 07/27/2018327k

pdf
Patiromer Commissioning Statement March 2020 13:53 04/30/2020158.4k

pdf
Pevanti Prednisolone Commissioning Statement May 15 09:11 07/10/2018212.2k

pdf
Pevanti Commissioning Statement Updated July 2020 14:50 09/23/2020118k

pdf
Pharmacological Intervention in ADHD Prescribing Algorithm 09:11 07/10/201827.2k

pdf
Pharmacological Management of Parkinsons Disease 2010 09:11 07/10/201831.4k

pdf
Pharmacy and Dispensing Practice Q&A Regarding EpiPen and EpiPen Junior Supply Issue (1) 09:29 11/13/20181k

pdf
Phosphate Binder Shared Care Guideline Final Aug 2020 12:04 10/12/2020221.5k

pdf
Plenadren Comissioning Statement Updated July 2020 10:23 08/19/2020190k

pdf
Plenadren Comissioning Statement Updated May 2017 09:11 07/10/2018511.2k

pdf
Policy and Pathway for Management of Hyperhidrosis 09:11 07/10/2018413.5k

pdf
Policy for Primary and Secondary Management of Osteoporosis March 2020 14:58 07/13/2020228.1k

pdf
Position Statement on the Prescribing of Preservative Free Eye Drops 09:11 07/10/2018198.4k

pdf
Potassium Citrate Stopping Criteria Letter 14:37 12/21/202292.1k

pdf
Pregabalin PSL April 2022 V2 12:23 11/01/2022168.3k

pdf
Pregabalin and Gabapentin Briefing Note 12 Feb 2019 08:42 02/21/2019276.5k

pdf
Pregabalin Statement Mar15 NHSE 09:11 07/10/201875.8k

pdf
Prescribable CGM CS 8 March 2023 Post DMAG (003) 11:49 05/18/2023166.9k

pdf
Prescribable CGM CS Sept 2023 09:50 10/23/2023144.2k

pdf
Prescribable CGM Commissioning Statement FINAL Dec 2022 10:35 12/21/2022168.5k

pdf
Prescribing of Quetiapine MR and IR Formulations 09:11 07/10/2018163.7k

pdf
Primary Care DVT Pathway NOAC 09:11 07/10/2018580.8k

pdf
Primary Care Management of High INR July 2017 09:11 07/10/2018637.5k

pdf
Private Prescribing in Primary Care 13:14 07/27/2018431.4k

pdf
Private Prescribing in Primary Care (1) 13:01 06/01/2022172.1k

pdf
Private Prescribing in Primary Care NHSD 16:03 02/01/2023166.5k

pdf
Prostate Cancer Chemo Algorithm 09:11 07/10/201813k

pdf
Proton Pump Inhibitor Deprescribing Algorithm (adults) PrescQIPP V2 September 2020 12:04 10/12/2020119.4k

pdf
Prucalopride Commissioning Statement March 2017 09:11 07/10/2018251.1k

pdf
Psoriasis Management May 19 12:28 08/02/2019641.4k

pdf
Psoriasis Management May 2018 09:11 07/10/2018794.9k

pdf
Psoriasis Management Sept 19 13:05 09/19/2019643.2k

pdf
Psoriasis Management Sept 19 (1) 09:58 10/17/2019643.2k

pdf
Psoriasis Management in Adults 2021 16:34 12/15/2021462.2k

pdf
Psoriasis Management in Adults April 21 13:14 08/23/2021350.9k

pdf
Psoriasis Management 2017 09:11 07/10/2018489.6k

pdf
Psoriasis Management in Adults March 17 09:11 07/10/2018482.8k

pdf
QTc Prolongation Guidance for Mental Health Prescribers 09:23 09/05/2019397.3k

pdf
Quick Formulary Guide Document (1) 11:11 06/30/2022103.4k

pdf
Quick Formulary Guide Document Aug 23 15:06 08/02/2023132k

pdf
RA Biologics Pathway July 2017 09:11 07/10/2018361.5k

pdf
RA Pathway for NICE TAs Jan 2018 09:11 07/10/2018368.6k

pdf
RBCH Methotrexate Policy 062019 16:32 09/17/2019712.2k

pdf
RMOC Combination Use of Biologics for Different Co Morbidities RMOC Regional Advisory Statement V1 July21 10:55 12/17/2021140.4k

pdf
Recording Medication Issued at Another Organisation 062021 15:28 07/08/2021285.8k

pdf
Reminder About Paediatric Amoxicillin Doses 09:11 07/10/2018207.8k

pdf
Renal Cell Cancer Chemo Algorithm 09:11 07/10/201823.8k

pdf
Revised INTERIM PROTOCOL ON DISPENSING OF ADRENALINE AUTOINJECTORS, 150microgram Applying from 5 November 2018 until Further Notification 09:26 11/13/2018257.5k

pdf
Revised Parkinsons Disease Guideline May 18 09:11 07/10/2018538.6k